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AbstrAct
Objectives To identify (1) the non-medical healthcare 
professionals in Wales qualified to prescribe medicines 
(including job title, employer, where the prescribing 
qualification is used, care setting and service provided); 
(2) the mode of prescribing used by these healthcare 
professionals, the frequency with which medicines are 
prescribed and the different ways in which the prescribing 
qualification is used; and (3) the safety and clinical 
governance systems within which these healthcare 
professionals practise.
Design National questionnaire survey.
setting All three National Health Service (NHS) Trusts and 
seven Health Boards (HB) in Wales.
Participants Non-medical prescribers.
results 379 (63%) participants responded to the survey. 
Most of these prescribers (41.1%) were specialist nurses 
who work in a variety of healthcare settings (primarily in 
secondary care) within each HB/NHS Trust, and regularly 
use independent prescribing to prescribe for a broad 
range of conditions. Nearly a quarter of the sample 
(22%) reported that prior to undertaking the prescribing 
programme, they had completed master’s level specialist 
training and 65.5% had 5 years qualified experience. Over 
half (55.8%) reported that there were plans to increase 
non-medical prescriber numbers within the team in which 
they worked. Only 7.1% reported they did not prescribe 
and the median number of items prescribed per week 
was between 21 and 30. Nearly all (87.8%) of the sample 
reported that they perceived prescribing to have ensured 
better use of their skills and 91.5% indicated that they 
believed it had improved the quality of care they were able 
to provide.
conclusion Non-medical prescribing has been 
implemented across the whole of Wales; however, its 
uptake within HBs and NHS Trusts has been inconsistent, 
and it has not been considered across all services, 
particularly those in primary care. Opportunities therefore 
exist to share learning across organisations.
IntrODuctIOn
The last two decades have seen signifi-
cant advances in the role and function 
of non-medical healthcare professionals 
(nurses, pharmacists and allied health 
professionals (AHPs)) who have developed 
innovative and extended roles in a number 
of countries including legislative authority 
to prescribe. Although non-medical health-
care professionals can prescribe in several 
countries including the UK, the USA, New 
Zealand, Netherlands, Ireland, Australia, 
Canada and Sweden,1–4 their scope of prac-
tice varies depending on the protocols and 
formularies in place. Drivers for this role 
include quicker and more efficient access to 
medicines, better use of healthcare profes-
sionals’ knowledge and skills, the need to 
reduce the workload of doctors and address 
doctor shortages, and the development of 
advanced practitioner roles.1
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Research
strengths and limitations of this study
 ► This is the first national survey of non-medical 
prescribing in Wales.
 ► Although data presented are the opinions of 
participants who completed the survey and, as such, 
may not represent the general population of non-
medical prescribers (NMP) in Wales, given the high 
response rate and the similar demographic profile 
of our sample to previous UK national evaluations 
of non-medical prescribing, we are confident that a 
non-response bias was minimal.
 ► The data collected were self-reported, and so 
information such as number of items prescribed 
is therefore likely to be estimated; however, our 
findings are similar to those of previous UK non-
medical prescribing national evaluations which 
indicates that this was not overly problematic.
 ► Only 606 NMPs (out of the 806 to whom the link to 
the online questionnaire was sent) acknowledged the 
email as delivered and read and this shortfall could 
have resulted in the proportion of NMPs working in 
primary care being lower than expected; however, 
information from the non-medical prescribing course 
commissioner for Wales (Workforce, Education and 
Development Service) identified that 166 of these 
individuals were based in secondary care and 31 in 
primary care (3 were unknown); we are therefore 
confident that this did not result in this shortfall.
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No other country in the world has such extended 
non-medical prescribing rights as the UK.1 The first 
group of non-medical prescribers (NMPs) in the UK to 
be provided with the capacity to prescribe was commu-
nity nurse practitioners. These nurses are able to 
prescribe from a limited list of medicines.5 Independent 
prescribing rights were extended in 2001 to include any 
first level registered nurse, with 3 years qualified expe-
rience,6 and in 2006 to include registered pharmacists 
with 2 years qualified experience.7 Within the last 3 years, 
registered AHPs (ie, physiotherapists, podiatrists/chirop-
odists, radiographers8) and optometrists,9 normally with 
3 years relevant postqualification experience, have also 
been provided with independent prescribing capability.
Apart from some restrictions around independent 
prescribing of controlled drugs (CDs) by AHPs, these 
non-medical healthcare professionals are able to 
prescribe any medicine within their area of competence 
independently, that is, they are responsible for the assess-
ment, diagnosis and decisions about the clinical manage-
ment required in patients with diagnosed or undiagnosed 
conditions. They are also able to prescribe as a supple-
mentary prescriber,10 which involves a written agree-
ment, between the patient, doctor and supplementary 
prescriber, on a list of medicines from which the supple-
mentary prescriber is able to prescribe. Supplementary 
prescribing is designed for the management of long-term 
conditions where patients have a confirmed diagnosis.
The number of NMPs in the UK has steadily increased 
over the last 5 years,11 and will continue to do so in order 
to fulfil the workforce needs of the National Health 
Service (NHS).12–14 The steady increase in these numbers 
has been facilitated by the model of prescribing training, 
typically 3–6 months in duration, which is funded by the 
government and only requires applicants to be at degree 
level. This contrasts with some countries (eg, the USA, 
Canada and Australia), where training to prescribe, 
also available to registered nurses, is at master’s level 
and is a component of the advanced nurse practitioner 
programme, usually 2 years in length.15
There are currently approximately 35 000 commu-
nity nurse practitioner prescribers, 30 000 nurse inde-
pendent/supplementary prescribers, 3000 pharmacist 
independent/supplementary prescribers and 600 AHPs 
and optometrists, with prescribing capability.11 Most of 
the available evidence relates to nurse and pharmacist 
prescribers and it is evident from this research that the 
majority of these prescribers work in general practice 
(GP) in primary care.16 17 Prescribing by these health-
care professionals is safe and clinically appropriate.17 
Stakeholders are generally satisfied with non-medical 
prescribing,18–23 and report that it increases the accessi-
bility and flexibility of services.23–25 A number of benefits 
for NMPs themselves have also been reported including 
greater autonomy and increased job satisfaction, more 
time with patients and the ability to provide a complete 
episode of care, increased self-confidence, time and cost 
savings.26–28 Although the numbers of NMPs continue 
to grow,29 there are, however, wide variations in these 
numbers both within and across organisations,16 17 29 30 
resulting in an inequality of service. Barriers to the imple-
mentation and continuation of non-medical prescribing 
have also been reported including restrictions of local 
arrangements (such as the inability to computer generate 
prescriptions), lack of peer support, organisational and 
policy restrictions, and difficulties in fulfilling continuing 
professional development (CPD) needs.16 31 Inconsisten-
cies in the clinical governance systems within which NMPs 
work have also been identified,16 and such variations can 
influence prescribing activity and its ongoing use.
NHS Wales delivers services through seven Health Boards 
(HBs) and three NHS Trusts with an all Wales focus. HBs 
include Aneurin Bevan University Health Board, Aber-
tawe Bro Morgannwg University Health Board, Cardiff 
and Vale University Health Board, Hywel Dda University 
Health Board, Cwm Taf University Health Board, Betsi 
Cadwaladr University Health Board (BCUHB) and Powys 
Teaching University Health Board. NHS Trusts include 
the Welsh Ambulance Service, Velindre NHS Trust and 
Public Health Wales. Primary care in Wales is provided by 
general practitioners and other healthcare professionals 
in health centres and services across Wales. Secondary 
care is delivered through the hospital and ambulance 
services. Tertiary care is provided by hospitals which treat 
particular types of illness such as cancer. Community care 
services are usually provided in partnership with local 
social services and delivered to patients in their homes. 
There is no evidence available with regard to the extent 
to which non-medical prescribing has been implemented 
within HBs and NHS Trusts in Wales. The aim of this study 
was to provide an overview of the uptake and implemen-
tation of non-medical prescribing in Wales. The specific 
objectives were to identify:
 ► the non-medical healthcare professionals qualified 
to prescribe medicines including job title, employer, 
where the prescribing qualification was used, care 
setting, service provided, years qualified as a prescriber 
and specialist training;
 ► the mode of prescribing used by these healthcare 
professionals, the frequency with which they prescribe 
and the different ways in which the prescribing quali-
fication is used;
 ► the safety and clinical governance systems within 
which these healthcare professionals practise.
MethODs
Design
A national online questionnaire survey.
Participants
NMPs working within all HBs and NHS Trusts within 
Wales.
Questionnaire
Bristol Online Survey—a tool for creating web surveys—
was used to develop an online questionnaire. The 
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Figure 1 Identification of sample. NHS, National Health Service; NMP, non-medical prescriber.
questionnaire used previously in England,16 and revised in 
order that it was appropriate to deliver to NMPs working 
in NHS Wales, was divided into four sections. Questions 
were mainly fixed choice with room for open-ended 
comment. Section 1 collected general demographic 
information including job title, job band (ie, a higher 
band/grade reflects salary/managerial responsibility/
clinical expertise; band 5/E=lower band/grade; band 8 
or 9/I=higher band/grade), employer, HB/NHS Trust in 
which the respondent was based, where the prescribing 
qualification was being used, contracted hours per week, 
age range, highest level of academic qualification, care 
setting, type of service provided (ie, hospital inpatient, 
hospital outpatient, community clinic, GP service, inde-
pendent sector, Her Majesty’s Prison Service, commu-
nity/intermediate care, out-of-hours), number of NMPs 
in the team and factors that hampered expanding these 
numbers. Section 2 asked questions specific to partic-
ipants’ prescribing background including the type of 
prescribing qualification held, number of years qualified 
as a prescriber, number of years’ experience in main area of 
prescribing practice prior to undertaking the prescribing 
programme, and specialist training undertaken prior to 
becoming a prescriber. Section 3 comprised questions 
about prescribing practice. Questions included whether 
participants prescribed, the method of prescribing 
currently used, the number of items prescribed per week 
and training experience since qualifying as a prescriber. 
A separate question also asked participants to indicate 
from a list of 10 statements the different ways in which 
they specifically used the prescribing qualification 
including the use of hospital medication charts, WP10/
WPH10 prescriptions (ie, prescription forms that can be 
dispensed on the NHS by prescribers), private prescrip-
tions, making recommendations to another provider (ie, 
even though a prescription is not produced, the same 
clinical decision making is undertaken) and remote 
prescribing. Participants were also asked in which ther-
apeutic areas they prescribed. The final section focused 
on clinical governance. Participants were asked to iden-
tify (from a list of 11 statements) the clinical governance 
systems in place within their organisation. This included 
such statements as whether or not participants’ employer 
had an up-to-date NMP policy in place, whether they 
had access to CPD and whether they had provided their 
employer with a specimen signature enabling pharma-
cists to check whether dispensed prescriptions are bona 
fide. They were also asked to indicate (using a 5-point 
Likert scale) from a list of 10 statements their experiences 
after the prescribing programme, including the extent to 
which they perceived prescribing had ensured better use 
of their skills, whether it had improved the quality of care 
they were able to provide, if peers/team members were 
supportive of the prescribing role, if they were able to 
prescribe all the medicines they needed in order to do 
their job, if they received an appropriate level of support 
from their employer, medical practitioner/other clini-
cian, if they were limited in their prescribing practice and 
reasons why. At the end of the questionnaire, participants 
were also asked to supply their contact details if they were 
interested in taking part in future research.
Data collection
Directors of the seven HBs and three NHS Trusts in Wales 
were contacted by the Workforce, Education and Devel-
opment Service (WEDS), the non-medical prescribing 
course commissioner for Wales, and asked for the names 
of NMPs within their HB/NHS Trust. Eight hundred and 
six NMPs were identified. These names were then checked 
against the global email system to identify individual 
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email addresses, and a link to the online questionnaire 
was distributed by WEDS to each of the 806 addresses. 
‘Delivery and Read’ receipts were attached. Only 606 of 
these emails were acknowledged as delivered and read, 
that is, 61 emails were undelivered and 139 were unread. 
Therefore, these 200 NMPs were removed from the 
sample (see figure 1). Data collection took place between 
March 2016 and June 2016.
ethical consideration
Ethical approval for the study was provided by the School 
of Healthcare Sciences Research Ethics Committee, 
Cardiff University.
Data analysis
Microsoft Excel and IBM SPSS V.17 were used for data 
entry and analysis. Descriptive statistics were used 
to describe the demographic nature of the sample. 
Content analysis,32 used to analyse free text comments, 
was undertaken to further explore qualitative findings. 
This process involved initial identification of commonly 
occurring themes, representing the range of responses. 
Themes were then broken down into mutually exclusive 
and exhaustive categories, and responses were assigned 
to categories and coded. The frequency of different 
responses was then counted. This process was performed 
manually.
results
Of the 606 participants who received and read the email 
containing the link to the survey, 379 (63%) responded.
General demographic information
The demographic data of the sample are presented in 
table 1.
Participants were from all seven HBs and two NHS 
Trusts, with the highest numbers (129 or 34.3%) based 
in BCUHB. Only 17 (4.5%) were based in Velindre NHS 
Trust. Three hundred and twenty-one (84.7%) respon-
dents were nurses, the largest majority (156 or 41.5%) 
of whom had specialist roles. Forty-six (12.1%) were 
pharmacists, nine (2.4%) were AHPs. Most participants 
(208 or 55.9%) were aged between 46 and 55 years, 264 
(71.4%) worked full-time and 226 (59.8%) were a band 
7. The majority of nurses (n=288 or 89%), all pharma-
cists (n=47 or 100%) and all AHPs (n=9 or 100%), were 
employed by NHS Trust/HB. Master’s and PhD qualifica-
tions were held by 210 (52.4%) respondents. The numbers 
of NMPs in healthcare teams varied. The median number 
of NMPs in healthcare teams was 2 (IQR from 1 to 4), and 
over half of the respondents (202 or 55.8%) indicated 
that there were plans to increase these numbers. Factors 
hampering expanding the numbers of NMPs in teams, 
identified from free text comments, included: lack of staff 
(n=33), workload and lack of time (n=60), and lack of 
funding (n=51).
Prescribing background
Over three-quarters of participants (307 or 79.5%) 
reported they were qualified nurse independent/supple-
mentary prescribers, 18 (4.7%) of whom indicated they 
were also qualified community practitioner prescribers, 
and 47 (12.4%) indicated they were pharmacist indepen-
dent/supplementary prescribers. Only small numbers 
(6 or 1.6%) were physiotherapist independent/and or 
supplementary prescribers. Fewer (1 or 0.3%) were podi-
atrist/chiropodist independent and/or supplementary 
prescribers, and two (0.5%) were radiographer supple-
mentary prescribers (see table 1). The majority of partici-
pants (280 or 76.2%) had been qualified to prescribe for 
more than 3 years and 243 (65.5%) indicated that they 
had more than 5 years’ experience in their area of prac-
tice before undertaking the prescribing programme. One 
hundred and fifty-one (22%) reported they had under-
taken master’s level specialist training in their area of 
prescribing practice.
Prescribing practice
Three hundred and twenty-seven (86.1%) partici-
pants reported that they currently used independent 
prescribing and 26 (6.8%) reported that they only 
used supplementary prescribing. Twenty-seven (7.1%) 
(including 21 nurses and 6 pharmacists) reported they 
did not prescribe. Reasons for not prescribing identified 
from free text comments included role change, that is, no 
longer a need to prescribe (n=15), a lack of support from 
employers and managers (n=8), and lack of confidence 
(n=2).
The number of items prescribed per week using 
independent prescribing is described in table 2. Partic-
ipants (n=333, 87.9%) reported on their independent 
prescribing, and the median number of items prescribed 
per week was 21–30 items (modal group was 1–5 items). 
Only 67 (17.7%) participants reported on their supple-
mentary prescribing, and the median number of items 
prescribed per week was 0 item (modal group was also 0 
item).
Therapy areas
The range of therapy areas for which participants 
prescribed is shown in figure 2.
Areas in which the greatest numbers of nurses reported 
that they prescribed included pain (121 or 37.1%), infec-
tions (116 or 35.9%), cardiovascular (105 or 32.6%) 
and minor ailments (82 or 25.4%). Greater numbers of 
pharmacists indicated that they prescribed for anticoag-
ulation (11 or 23.4%), pain (8 or 17%), cardiovascular 
(7 or 14.9%) and gastroenterology (7 or 14.9%). Pain (5 
or 55.5%), musculoskeletal (4 or 44.4%) and wound care 
(4 or 44.4%) were the areas in which higher numbers of 
AHPs reported they prescribed.
Ways in which the prescribing qualification is used
Prescribers reported that they used a range of methods 
to use their prescribing qualification (see figure 3); the 
group.bmj.com on September 25, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 5Courtenay M, et al. BMJ Open 2017;7:e015313. doi:10.1136/bmjopen-2016-015313
Open Access
Table 1 Demographic details
n %
Clinical role
  Specialist nurses (clinical nurse specialists, specialist nurse practitioners, nurse clinician, paediatric specialist 
nurse)
156 41.5
  Community nurses (community matron, children’s community nurse, health visitor, district nurse, school nurse) 18 4.8
  General practice nurses (practice nurses and nurse practitioners) 88 23.4
  Senior clinical nurses (nurse consultant, lead nurse, ward manager, sister, charge nurse, team leader, modern 
matron)
38 10.1
  Mental health nurses (community psychiatric nurse, primary care link worker, liaison nurse, clinical coordinator) 8 2.1
  Nurse managers (director of nursing, service lead, information manager) 13 3.5
  Pharmacists (team leader/manager, senior clinical pharmacist, senior pharmacist (care homes, elderly, 
transplant), education and training pharmacist, community pharmacist, practice support pharmacist)
46 12.2
  Physiotherapists 4 1.1
  Podiatrists/chiropodists 1 0.3
  Radiographers 2 0.5
  Optometrists 0 0.0
  Other 2 0.5
HB/NHS Trust based
  Aneurin Bevan University Health Board 59 15.7
  Abertawe Bro Morgannwg University Health Board 48 12.8
  Cardiff and Vale University Health Board 53 14.1
  Hywel Dda University Health Board 24 6.4
  Cwm Taf University Health Board 27 7.2
  Betsi Cadwaladr University Health Board 129 34.3
  Powys Teaching University Health Board 18 4.8
  Welsh Ambulance Service Trust 0 0.0
  Velindre NHS Trust 17 4.5
  Public Health Wales 1 0.3
Where prescribing qualification used
  General practice 48 12.2
  NHS Trust 146 37.0
  Health Board 191 48.4
Care setting
  Primary 58 13.9
  Secondary 205 49.2
  Primary and secondary 48 11.5
  Community 68 16.3
  Tertiary 30 7.2
Service provided
  NHS hospital inpatient 176 30.0
  NHS hospital outpatient 193 32.9
  NHS community clinic 46 7.8
  General practice service 56 9.5
  Independent sector 3 0.5
  Her Majesty’s Prison Service 3 0.5
  Community/intermediate care 63 10.7
  Out-of-hours 26 4.4
Continued
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n %
Highest level of academic qualification
  Diploma 27 6.7
  Degree 95 23.7
  Postgraduate diploma 69 17.2
  Master’s 204 50.9
  PhD 6 1.5
Prescribing qualification
  Community practitioner nurse prescriber (v100) 19 4.9
  Community practitioner prescriber without a specialist qualification (v150) 4 1.0
  Nurse independent/supplementary prescriber (v200 and v300) 307 79.5
  Pharmacist supplementary prescriber 2 0.5
  Pharmacist independent/supplementary prescriber 45 11.7
  Physiotherapist supplementary prescriber 1 0.3
  Physiotherapist independent/supplementary prescriber 5 1.3
  Podiatrist/chiropodist supplementary prescriber 1 0.3
  Podiatrist/chiropodist independent/supplementary prescriber 0 0.0
  Radiographer supplementary prescriber 2 0.5
  Optometrist supplementary prescriber 0 0.0
  Optometrist independent/supplementary prescriber 0 0.0
Years qualified as a prescriber
  Less than 1 year 4 1.1
  1–3 years 86 23.2
  4–5 years 95 25.7
  More than 5 years 185 50.0
Experience in main area of prescribing practice before undertaking the prescribing programme
  Under 1 year 23 6.2
  1–3 years 63 17.0
  4–5 years 42 11.3
  Over 5 years 243 65.5
Specialist training undertaken prior to prescribing programme
  Accredited study days 128 18.6
  Master’s level module/s 151 22.0
  Degree level modules 154 22.4
  Diploma/postgraduate level modules 123 17.9
  No specialist training 27 3.9
  Other training (eg, drug company study days/conference) 104 15.1
Method of prescribing currently used
  Independent prescribing 327 86.1
  Supplementary prescribing 26 6.8
  Do not prescribe 27 7.1
 Owing to missing data from participants who chose not to disclose demographic information the percentages do not always equal 100%. 
‘Where prescribing qualification used’ adds up to more than 100% as some participants were prescribing in more than one area. Each of the 
categories under ‘Clinical role’ is mutually exclusive.
HB, Health Board; NHS, National Health Service.
Table 1 Continued 
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Table 2 Number of items prescribed in a typical week using independent prescribing
Nurses Pharmacists AHPs
n % n % n %
How many items do you prescribe in a typical week as IP?
  0 14 4.8 4 9.1 0 0.0
  1–5 72 24.9 13 29.5 3 75.0
  6–10 47 16.3 7 15.9 0 0.0
  11–20 51 17.6 5 11.4 1 25.0
  21–30 37 12.8 7 15.9 0 0.0
  31–40 16 5.5 1 2.3 0 0.0
  41–50 11 3.8 2 4.5 0 0.0
  Over 50 41 14.2 5 11.4 0 0.0
AHP, allied health professional; IP, independent prescribing.
Figure 2 Therapy areas in which NMPs prescribed. AHP, allied health professional; NMP, non-medical prescriber.
most frequently reported by 20% of nurses and 25% of 
pharmacists included prescribing via hospital medica-
tion charts. Other methods reported by nurses included 
issuing private prescriptions to patients (3 or 0.9%) and 
making recommendations via letter/email or telephone 
call to GP for medicines to be prescribed (35 or 10%). A 
narrower range of methods was reported by pharmacists 
and included remote prescribing by telephone, email 
or fax (1 or 2.1%) and making recommendations via 
patient’s hospital notes for medicines to be prescribed (3 
or 6.4%). The few methods reported by AHPs included 
making recommendations for patients to buy over-the-
counter medicines (1 or 11.1%).
Governance and support
Some systems (such as the provision of a specimen signa-
ture, and agreed scope of practice) were reported to be 
in place by a high number of prescribers (see figure 4). 
However, only a small proportion of nurses (44 or 13%) 
reported they were able to monitor/access their own 
prescribing data, were provided with regular data to 
monitor their own prescribing practice (99 or 30%) or 
were involved in the development of local formularies 
and guidance (126 or 39%). Similarly, only 20 (42%) of 
pharmacists reported they had access to their prescribing 
data.
experience after the prescribing programme
High numbers of respondents (333 or 87.8%) reported 
that they perceived prescribing to have ensured better use 
of their skills, and 347 (91.5%) believed that the ability 
to prescribe had improved the quality of care they were 
able to provide. Three hundred and forty-seven (91.5%) 
indicated that peers/team members were supportive of 
the prescribing role, and 308 or 81.2% indicated that 
they were able to prescribe all the medicines they needed 
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Figure 3 Ways in which the prescribing qualification was used. AHP, allied health professional; GP, general practice; NMP, non-
medical prescriber.
Figure 4 Safety and clinical governance systems in place. AHP, allied health professional; CPD, continuing professional 
development; NMP, non-medical prescriber.
in order to do their job. However, 67 (17.7%) reported 
that they did not receive an appropriate level of support 
from their employer and 83 (21.9%) indicated that they 
did not receive continued support from a medical practi-
tioner/other clinician. Fifty-eight (15.3%) reported that 
they were limited in their prescribing practice. Reasons 
identified from free text comments included role change, 
that is, no longer a need to prescribe (n=11), a lack of 
support from employers, managers and senior team 
members (n=8), legislative restrictions around CDs 
(n=7), a lack of prescription pad (n=6) and local formu-
lary restrictions (n=5).
DIscussIOn
statement of principal findings
NMPs in Wales are primarily specialist nurses who work 
in a variety of healthcare settings and regularly use 
independent prescribing to issue prescriptions directly to 
patients and prescribe via hospital medication charts for 
a broad range of conditions. Participants reported that 
prescribing made better use of their skills, and improved 
the quality of care they were able to provide. Although 
non-medical prescribing has been implemented across 
the whole of Wales, its uptake within HBs and NHS Trusts 
has been inconsistent, and has been primarily imple-
mented within secondary care organisations.
strengths and weaknesses
This is the first national study to provide detailed informa-
tion about the uptake and implementation of non-med-
ical prescribing in Wales. Data presented in this paper 
are the opinions of subjects who accepted the invitation 
to participate in the study and as such, may not repre-
sent the general population of NMPs. However, given the 
high response rate and the similar demographic profile 
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of our sample (including the ratio of nurse, pharmacist 
and AHP prescribers) to previous UK national evalua-
tions of non-medical prescribing,17 we are confident that 
a non-response bias was minimal and that our findings 
present an accurate picture of this population. Given 
the data collected were self-reported, information such 
as number of items prescribed is likely to have been esti-
mated. However, the results of previous UK NMP eval-
uations16 are comparable suggesting that this was not 
overly problematic. Although 379 (63%) participants 
responded, this represents less than half of the popula-
tion of the 806 NMPs that were originally identified by 
directors of HBs and NHS Trusts as those working in 
Wales. Furthermore, as the proportion of NMPs working 
in primary care is lower than that reported in other UK 
national surveys, it is possible that this could have been 
a result of this shortfall. However, information from the 
non-medical prescribing course commissioner for Wales 
(WEDS) identified that of the 200 emails undelivered/
unread, 166 of these individuals were based in secondary 
care and 31 in primary care; we are therefore confident 
that this did not result in this shortfall.
comparison with other studies
NMPs in Wales are primarily specialist nurses, employed 
by all NHS Trusts/HBs, who prescribe in-hospital inpa-
tient and outpatient services. In line with the findings of 
previous UK national research,17 the uptake of non-med-
ical prescribing by HBs/NHS Trusts has been inconsis-
tent. However, in contrast to our finding that most NMPs 
were based in secondary care, the results of these studies, 
and other international evidence,1–4 indicate that NMPs 
predominantly work in primary care.
Similar to previous research,16 17 over three-quarters 
of our sample had over 4 years’ experience in their area 
of prescribing practice prior to undertaking training to 
prescribe and around two-thirds held a diploma/degree/
master’s specialist qualification. Although prescribing 
rates varied among different groups, aligned with 
previous evidence,16 17 nearly all respondents reported 
they prescribed; the main reason given for not prescribing 
being no longer working in a role that required this 
activity.
In line with findings of a metasynthesis analysis of 
the nurse prescribing literature,33 a lack of funding to 
support the prescribing role was identified as a barrier 
to expanding NMP numbers. NMPs reported that they 
prescribed independently across a broad range of thera-
peutic areas, and consistent with non-medical prescribing 
research,16 17 34 35 greater numbers of nurses indicated 
they prescribed for infections, higher numbers of phar-
macists indicated they prescribed for pain, and musculo-
skeletal conditions were those for which larger numbers 
of AHPs prescribed. Supplementary prescribing was used 
infrequently and this has been reported previously.16
As well as issuing prescriptions directly to patients and 
prescribing via hospital medication charts, NMPs reported 
they used their prescribing qualification to undertake a 
range of other activities including making recommenda-
tions via letter/email or telephone call to GP for medi-
cines to be prescribed, remote prescribing by telephone, 
email or fax, and making recommendations via patient’s 
hospital notes. This is in line with earlier evidence.16
For the most part, clinical governance arrangements 
were reported to be working, with the exception of the 
ability to obtain prescribing data and monitor or audit 
prescribing activity. This has been reported previously.16
Meaning of the study: possible explanations and implications 
for clinicians and policymakers
The wide variance in non-medical prescribing, and partic-
ularly the higher proportion of NMPs in secondary care, 
and its lack of use by primary care organisations, suggests 
that non-medical prescribing has not been viewed as part 
of a multidisciplinary whole workforce approach to meet 
service needs/gaps. However, this seems to be changing, 
as both the Carter Review in England14 and the Work-
force Plan for Primary Care in Wales36 refer to the role 
independent prescribers could have in fulfilling the work-
force needs of the NHS. Opportunities therefore exist for 
commissioners of services to share learning across organ-
isations. Where prescribing has been implemented, it is 
being used and so predicted services are being delivered.
unanswered questions and future research
Given the development of primary care services in the 
UK,12 36 an important next step would be to explore the 
lack of use of non-medical prescribing in these services 
in Wales. Evidence is available that has demonstrated the 
benefits of non-medical prescribing and its acceptability to 
patients; however, most of this work has been undertaken 
in primary care. A useful next step would be to explore its 
acceptability to patients and benefits in secondary care. 
Research designed to compare the processes, outcomes 
and costs of care for patients managed by medical and 
NMPs would also be valuable for those engaged in service 
redesign and workforce planning.
cOnclusIOn
Non-medical prescribing has been implemented across 
the whole of Wales; however, its uptake within HBs 
and NHS Trusts has been inconsistent, and it has not 
been considered across all services, particularly those 
in primary care. Opportunities therefore exist to share 
learning across organisations.
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